Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". - Wikidata - awgldk - TriplyDB

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

http://www.wikidata.org/entity/Q34518902

about

Age-related differences in 1p and 19q deletions in oligodendrogliomas Survey of treatment recommendations for anaplastic oligodendroglioma Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Imaging in neurooncology Molecular classification of human gliomas using matrix-based comparative genomic hybridization.Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells.OLIG-1 and 2 gene expression and oligodendroglial tumours.Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.Oligodendrogliomas: an update on basic and clinical research.MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells.Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.Molecular diagnosis of metastasizing oligodendroglioma: a case report.Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization.Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: case study.Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.Molecular genetic analysis of oligodendroglial tumors.Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.Oligodendroglioma: impact of molecular biology on its definition, diagnosis and management.DNA replication licensing and cell cycle kinetics of oligodendroglial tumours.Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.Molecular neuropathology of gliomas.Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.Pathology and genetics of diffuse gliomas in adults.Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.Correlation of in vitro infiltration with glioma histological type in organotypic brain slices.Histology-based expression profiling yields novel prognostic markers in human glioblastoma.Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion.High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization.Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.Characterization of low-grade gliomas using RGB color maps derived from ADC histograms.

P2860

Q24805918-0B8BAADA-13BC-4953-9054-76785D42F8E1 Q30441461-6E702EA9-8A63-4EDD-BF38-52A3858CC38B Q30775012-84828563-172F-45F5-A4C3-66413021AE82 Q30989939-35DA9D46-CD15-4896-AF8D-126EE879C028 Q33214806-275154A8-9BFB-4B20-9F4F-22B48E6674AD Q33636469-D86E7A2A-FD85-4DD3-8226-24D456EF8374 Q33784207-B75613DC-ACC0-4315-9ED3-F4A7D0E6B752 Q34115844-B4D13AB5-5E85-4EFF-802F-31EBD9E665F2 Q34612308-993DFFCD-2DBE-40EE-9703-BE99AF2AE6BC Q35063647-CA84FC8B-BF10-4C4A-AAA5-944FA3BB1683 Q35070122-154BE52D-81ED-4B06-85E3-05DBD730BCB3 Q35105809-6669B466-AD77-4CFD-9479-867D7BA4EE4F Q35419344-522D30EF-DE20-4F1D-A6D1-DE68D9671877 Q35608413-AF26032E-8829-4D3C-AD3E-DB5153AD32CB Q35673519-E646927F-1D52-4979-8AD4-748E195F78CB Q35789692-BA74CF4C-0CC3-4F94-827A-D67E034F96F7 Q35790152-344B7BAF-7AB1-48CF-95AD-9C0115983554 Q35799829-9067A31B-DD21-420E-8400-A28FBD33D0B6 Q35864945-53C99906-8904-4E0A-9804-0544132995CF Q36044175-EFEB57F9-84F1-40BC-9394-A5239F546BA0 Q36140650-A090D04D-12B8-4CAF-87A0-2C7D1C10D52E Q36272041-3761FC15-6939-4EFC-A0AF-FC72E69CEDCE Q36695341-7E0D3D64-44DC-4A94-8458-4F9E25096571 Q36699109-96FF6E2B-9748-4E47-ACBF-BF8CD4E46818 Q37168291-330D81A2-5ECE-4D50-A3FA-D86D15BC3FBF Q37285711-45AEC741-063F-4948-9BDC-874EF2F86507 Q37427424-D3133975-0A87-46B8-B474-43C00C79959A Q37429908-0193AEE9-B850-4A4F-B9C0-00120B3E9758 Q38368235-2A254930-0D5C-4B23-A22C-53C481EEC137 Q39476804-3D8B1E5A-DB86-40C3-9976-9382F2100B8C Q42157104-71815F3D-6651-4986-A30B-D443C803B061 Q43054130-CE9CD70F-A5FA-4FDA-98D0-793B3A1576FA Q46044500-AC33C46B-5657-4231-8EC9-1AD481AFDA3F Q48159065-75289E0A-09C2-430E-8D59-21046B861ED7 Q48229074-7201B4ED-4F55-4506-8BCD-02B60899A1AE Q48253684-48674B9A-E8E8-4824-A668-B278E70849F8 Q48261931-B3EFF9C9-DF69-4C14-AD3C-682FABEA3019 Q48263988-6B9EE34F-D6EE-421F-8774-8E85C98AEABA Q48326545-F88B8A3D-58AB-4661-8A79-B02DCA2E5D3D Q48552322-33D247EA-ACCE-4203-B937-E012C26D3234

P2860

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

http://www.wikidata.org/entity/Q34518902

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@ast

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@en

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@nl

type

label

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@ast

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@en

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@nl

prefLabel

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@ast

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@en

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@nl

P1433

Q34518902-6FFC363A-DE09-4A5F-97A6-8FAE1A878E31

P1476

Q34518902-CE6E145F-2C83-4900-8045-9C60CC69E015

P2093

Q34518902-175D3A00-1CCB-44AE-888D-A5321D1E01F6

Q34518902-682B22F8-3606-4E27-99DD-444C700453D5

Q34518902-7A6B09B2-A672-4E07-91B5-D116DB361BB9

Q34518902-8130CBE5-E842-4B70-AD4A-D2FA12FE8F4E

Q34518902-9023B7E7-36F9-418E-B8AB-E8B618574427

Q34518902-B7125977-7DBF-437C-8DD6-A3A1A8E3824C

Q34518902-D93A8DAE-2087-4A3E-B202-65F3BCB12C1B

P2860

Q34518902-0153E02B-B6A9-4ED4-8DAD-F28970CFDED8

Q34518902-30A732A9-BDDC-4F14-A25A-101C6B104D37

Q34518902-37EF7825-1437-4168-A950-5F8A34215937

Q34518902-51C8D269-B6DA-43EB-947D-0D6E64CDF8C6

Q34518902-94518781-C60E-4754-A050-29C5726D6498

Q34518902-D3E960ED-444A-4FC2-B53D-BF7F3CC6BABB

Q34518902-F698A250-DC4D-44DE-8FAC-9CF4F7628713

Q34518902-FAEE975C-F356-4E70-97DE-0559B9395B37

P304

Q34518902-2D7CA9A1-5945-45D6-9A4A-C10E7700024C

P31

Q34518902-A20FD584-731C-419C-A5C2-329552424992

P356

Q34518902-EE5CADBF-F910-4F32-B859-C90148E1BF39

P433

Q34518902-C0A1C273-E822-4C12-859B-97573301F95C

P478

Q34518902-4D9EADA1-9CF4-4E3D-B4A8-7AECF65E13DD

P577

Q34518902-A0B141C0-F624-4548-B9D0-097D4627C33F

P5875

Q34518902-426EC06B-F9B4-4897-85DC-03405AC5DD27

P698

Q34518902-187D8393-46FD-49E7-99DB-98FA847938CE

P921

Q34518902-4B073C95-968E-4ABA-8159-93E7B332FB94

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Histopathological-molecular ge ...... low-grade "oligodendroglioma".

@en

P2093

Andrea N Cutone

http://www.w3.org/2001/XMLSchema#string

David N Louis

http://www.w3.org/2001/XMLSchema#string

Hikaru Sasaki

http://www.w3.org/2001/XMLSchema#string

J Gregory Cairncross

http://www.w3.org/2001/XMLSchema#string

Loki B Johnk

http://www.w3.org/2001/XMLSchema#string

Magdalena C Zlatescu

http://www.w3.org/2001/XMLSchema#string

Rebecca A Betensky

http://www.w3.org/2001/XMLSchema#string

P2860

Glioma classification: a molecular reappraisal.

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas.

Response criteria for phase II studies of supratentorial malignant glioma.

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

P304

58-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/61.1.58

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11531754

http://www.w3.org/2001/XMLSchema#string

P698

11829344

http://www.w3.org/2001/XMLSchema#string

P921

oligodendroglioma